Aug 26 2010 | News
GENEVA (AP) — Novartis AG says it has completed its purchase of Nestle SA's 77 percent stake in eye care firm Alcon Inc. at a total cost of $38.7 billion.
|
Feb 12 2010 | News
NEW YORK (AP) — Eye-care products company Alcon Inc. on Thursday said its fourth-quarter earnings rose 8 percent on higher prescription product demand in the U.S. and higher sales to emerging markets.
|
Jan 20 2010 | News
GENEVA (AP) — A panel of directors at eye-care company Alcon Inc. on Wednesday rejected as "grossly inadequate" a $39 billion takeover bid by Swiss pharmaceutical giant Novartis AG.
|
Jan 19 2010 | News
Alcon announced today that it will purchase the rights in the United States for two FDA-approved topical eye care products from Sirion Therapeutics, Inc.
|
Jan 11 2010 | News
GENEVA (AP) — The minority shareholders of eye-care products maker Alcon, Inc. have filed a class-action lawsuit to prevent Swiss pharmaceutical giant Novartis AG from completing a $39 billion takeover of the company.
|
Jan 4 2010 | News
BASEL, Switzerland (AP) — Novartis AG said Monday it plans to take over Alcon Inc. by paying $38.5 billion for the 77 percent stake it does not already own in a deal that would make it one of the biggest players in the global market for eye-care products.
|
Dec 17 2009 | News
NovaBay Pharmaceuticals, Inc., a clinical stage biopharmaceutical company creating a new class of anti-infectives for treating multi-drug resistant pathogens, announced today that effective immediately, its partner, Alcon Inc.
|
Oct 22 2009 | News
ELIANE ENGELER Associated Press Writer GENEVA (AP) — Novartis AG posted Thursday a 1 percent increase in third-quarter net profit on strong sales of pharmaceuticals, such as its new Afinitor drug against kidney cancer, and raised its full-year outlook after the approval of its swine flu vaccines.
|
Sep 14 2009 | News
Alcon has entered into a definitive agreement to acquire ESBATech AG, a Swiss biotechnology company.
|
Aug 31 2009 | News
BEN DOBBIN AP Business Writer ROCHESTER, N.Y. (AP) — Bausch & Lomb Inc., rocked by the worldwide recall of its flagship contact lens solution in 2006, has beaten back scientific claims blaming ReNu with MoistureLoc cleaner for a flurry of non-fungal eye infections.
|